191 related articles for article (PubMed ID: 2073222)
21. Comparison of the efficacy and tolerability of moclobemide and maprotiline in depressed patients treated by general practitioners.
Gachoud JP; Dick P; Köhler M
Clin Neuropharmacol; 1994; 17 Suppl 1():S29-37. PubMed ID: 7954482
[TBL] [Abstract][Full Text] [Related]
22. Review of comparative clinical trials. Moclobemide vs tricyclic antidepressants and vs placebo in depressive states.
Stabl M; Biziére K; Schmid-Burgk W; Amrein R
J Neural Transm Suppl; 1989; 28():77-89. PubMed ID: 2677244
[TBL] [Abstract][Full Text] [Related]
23. Open comparative randomised study of moclobemide versus amitriptyline in major depressive illness (DSM IIIR) in Nigeria.
Ononye F; Sijuola OA; Chukwuani CM; Mume OC; Makanjuola RO
West Afr J Med; 2000; 19(2):148-53. PubMed ID: 11070752
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of moclobemide compared with maprotiline in treatment of major depressive disorder. A double-blind multicenter study with parallel groups.
Steinmeyer EM; Vorbach EU; Arnoldt KH
Pharmacopsychiatry; 1993 Nov; 26(6):246-53. PubMed ID: 8127929
[TBL] [Abstract][Full Text] [Related]
25. [Multicenter study comparing efficacy and tolerance of moclobemide and fluvoxamine in hospitalized and ambulatory patients with severe depressive episodes].
Barrelet L; Blajev B; Bolzani L; de Saussure C; Kasas A; Van H; Gachoud JP
Schweiz Rundsch Med Prax; 1991 May; 80(19):524-8. PubMed ID: 1904620
[TBL] [Abstract][Full Text] [Related]
26. Moclobemide versus fluoxetine for major depressive episodes.
Geerts S; Bruynooghe F; De Cuyper H; Demeulemeester F; Haazen L
Clin Neuropharmacol; 1994; 17 Suppl 1():S50-7. PubMed ID: 7954484
[TBL] [Abstract][Full Text] [Related]
27. Multicenter double-blind study of moclobemide and maprotiline.
Vaz-Serra A; Figueira ML; Firmino H; Albuquerque AJ; Jara JM; Pestana LC
Clin Neuropharmacol; 1994; 17 Suppl 1():S38-49. PubMed ID: 7954483
[TBL] [Abstract][Full Text] [Related]
28. Moclobemide versus clomipramine in the treatment of depression: a single-centre study, Federal Republic of Germany.
Funke HJ; Moritz E; Hellstern K; Malanowski H
Acta Psychiatr Scand Suppl; 1990; 360():46-7. PubMed ID: 2248069
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and tolerability of moclobemide compared with imipramine in depressive disorder (DSM-III): an Austrian double-blind, multicentre study.
Baumhackl U; Bizière K; Fischbach R; Geretsegger C; Hebenstreit G; Radmayr E; Stabl M
Br J Psychiatry Suppl; 1989 Oct; (6):78-83. PubMed ID: 2695130
[TBL] [Abstract][Full Text] [Related]
30. RIMA--a new concept in the treatment of depression with moclobemide.
Amrein R; Hetzel W; Stabl M; Schmid-Burgk W
Int Clin Psychopharmacol; 1993 Jan; 7(3-4):123-32. PubMed ID: 8468432
[TBL] [Abstract][Full Text] [Related]
31. A double-blind comparison of moclobemide and fluoxetine in the treatment of depressive disorders.
Williams R; Edwards RA; Newburn GM; Mullen R; Menkes DB; Segkar C
Int Clin Psychopharmacol; 1993 Jan; 7(3-4):155-8. PubMed ID: 8468437
[TBL] [Abstract][Full Text] [Related]
32. Moclobemide--placebo-controlled trials.
Silverstone T
Int Clin Psychopharmacol; 1993 Jan; 7(3-4):133-6. PubMed ID: 8468433
[TBL] [Abstract][Full Text] [Related]
33. Moclobemide (Ro 11-1163) versus desipramine in the treatment of endogenous depression.
Gabelic I; Moll E
Acta Psychiatr Scand Suppl; 1990; 360():44-5. PubMed ID: 2248068
[TBL] [Abstract][Full Text] [Related]
34. Double-blind comparison of moclobemide, imipramine and placebo in depressive patients.
Ucha Udabe R; Márquez CA; Traballi CA; Portes N
Acta Psychiatr Scand Suppl; 1990; 360():54-6. PubMed ID: 2123367
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic efficacy of antidepressants in agitated anxious depression--a meta-analysis of moclobemide studies.
Delini-Stula A; Mikkelsen H; Angst J
J Affect Disord; 1995 Oct; 35(1-2):21-30. PubMed ID: 8557884
[TBL] [Abstract][Full Text] [Related]
36. Clinical, biochemical and psychometric findings with the new MAO-A-inhibitors moclobemide and brofaromine in patients with major depressive disorder.
Laux G; Classen W; Sofic E; Becker T; Riederer P; Lesch KP; Struck M; Beckmann H
J Neural Transm Suppl; 1990; 32():189-95. PubMed ID: 2089089
[TBL] [Abstract][Full Text] [Related]
37. Moclobemide in elderly patients with cognitive decline and depression: an international double-blind, placebo-controlled trial.
Roth M; Mountjoy CQ; Amrein R
Br J Psychiatry; 1996 Feb; 168(2):149-57. PubMed ID: 8837903
[TBL] [Abstract][Full Text] [Related]
38. Moclobemide versus fluoxetine for double depression: a randomized double-blind study.
Duarte A; Mikkelsen H; Delini-Stula A
J Psychiatr Res; 1996; 30(6):453-8. PubMed ID: 9023788
[TBL] [Abstract][Full Text] [Related]
39. A multicentre comparative trial of moclobemide, imipramine and placebo in major depressive disorder. UK Moclobemide Study Group.
Int Clin Psychopharmacol; 1994; 9(2):109-13. PubMed ID: 8056992
[TBL] [Abstract][Full Text] [Related]
40. Moclobemide (Ro 11-1163) versus imipramine in the treatment of depression.
Casacchia M; Moll E
Acta Psychiatr Scand Suppl; 1990; 360():43. PubMed ID: 2248067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
